264 related articles for article (PubMed ID: 33152749)
1. Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.
Pal M; Bao W; Wang R; Liu Y; An X; Mitchell WB; Lobo CA; Minniti C; Shi PA; Manwani D; Yazdanbakhsh K; Zhong H
Blood; 2021 Jan; 137(2):269-280. PubMed ID: 33152749
[TBL] [Abstract][Full Text] [Related]
2. Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.
Godefroy E; Liu Y; Shi P; Mitchell WB; Cohen D; Chou ST; Manwani D; Yazdanbakhsh K
Haematologica; 2016 Sep; 101(9):1028-38. PubMed ID: 27229712
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of sickle cell alloimmunization.
Yazdanbakhsh K
Transfus Clin Biol; 2015 Aug; 22(3):178-81. PubMed ID: 26056038
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory networks in sickle cell alloimmunization.
Yazdanbakhsh K
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):457-461. PubMed ID: 27913516
[TBL] [Abstract][Full Text] [Related]
5. Hemin controls T cell polarization in sickle cell alloimmunization.
Zhong H; Bao W; Friedman D; Yazdanbakhsh K
J Immunol; 2014 Jul; 193(1):102-10. PubMed ID: 24879794
[TBL] [Abstract][Full Text] [Related]
6. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
[TBL] [Abstract][Full Text] [Related]
7. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity.
Bains SK; Foresti R; Howard J; Atwal S; Green CJ; Motterlini R
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):305-12. PubMed ID: 19965783
[TBL] [Abstract][Full Text] [Related]
8. Immune Regulation of sickle Cell Alloimmunization.
Yazdanbakhsh K; Shaz BH; Hillyer CD
ISBT Sci Ser; 2017 Feb; 12(1):248-253. PubMed ID: 28261322
[TBL] [Abstract][Full Text] [Related]
9. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients.
Costa Neto A; Santos F; Ribeiro I; Oliveira V; Dezan M; Kashima S; Covas D; Pereira A; Fonseca G; Moreira F; Krieger J; Gualandro S; Rocha V; Mendrone A; Dinardo CL
Transfusion; 2020 Jul; 60(7):1573-1578. PubMed ID: 32681817
[TBL] [Abstract][Full Text] [Related]
10. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
[TBL] [Abstract][Full Text] [Related]
11. Alloimmunization and hyperhemolysis in sickle cell disease.
Pirenne F; Pondarré C
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):653-659. PubMed ID: 38066873
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Balbuena-Merle R; Hendrickson JE
Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
[TBL] [Abstract][Full Text] [Related]
13. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
Telen MJ; Afenyi-Annan A; Garrett ME; Combs MR; Orringer EP; Ashley-Koch AE
Transfusion; 2015 Jun; 55(6 Pt 2):1378-87. PubMed ID: 25444611
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
[TBL] [Abstract][Full Text] [Related]
18. Hemolysis and immune regulation.
Zhong H; Yazdanbakhsh K
Curr Opin Hematol; 2018 May; 25(3):177-182. PubMed ID: 29461260
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of alloimmunization in sickle cell disease.
Hudson KE; Fasano RM; Karafin MS; Hendrickson JE; Francis RO
Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335
[TBL] [Abstract][Full Text] [Related]
20. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
